ANCA-associated vasculitis (AAV) is a group of disorders that is caused by inflammation affecting small blood vessels. AAV includes microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA) renamed from Wegener’s granulomatosis, and eosinophilic granulomatosis with polyangiitis (EGPA), renamed from Churg-Strauss syndrome. AAV can be considered a complex disease; in fact, both genetic and environmental factors are involved in its susceptibility. To improve the understanding of the disease, the genetic component has been extensively studied by candidate association studies and genome-wide association studies. Most of the identified genetic AAV risk factors are common variants, which still needs further investigation to clarify their importance. In this chapter, we discuss the results of genetic studies in AAV. We also present novel approaches to identifying the causal variants in complex susceptibility loci and disease mechanisms. Finally, we discuss the limitations of current methods and the challenges that we still have to approach in order to translate genomic and epigenomic data into clinical practice.

Genetics of ANCA-Associated Vasculitis / F. Alberici, P. Anthony Lyons, D. Martorana (RARE DISEASES OF THE IMMUNE SYSTEM). - In: Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis / [a cura di] R.A. Sinico, L. Guillevin. - [s.l] : Springer, 2019. - ISBN 9783030022389. - pp. 19-32

Genetics of ANCA-Associated Vasculitis

F. Alberici;
2019

Abstract

ANCA-associated vasculitis (AAV) is a group of disorders that is caused by inflammation affecting small blood vessels. AAV includes microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA) renamed from Wegener’s granulomatosis, and eosinophilic granulomatosis with polyangiitis (EGPA), renamed from Churg-Strauss syndrome. AAV can be considered a complex disease; in fact, both genetic and environmental factors are involved in its susceptibility. To improve the understanding of the disease, the genetic component has been extensively studied by candidate association studies and genome-wide association studies. Most of the identified genetic AAV risk factors are common variants, which still needs further investigation to clarify their importance. In this chapter, we discuss the results of genetic studies in AAV. We also present novel approaches to identifying the causal variants in complex susceptibility loci and disease mechanisms. Finally, we discuss the limitations of current methods and the challenges that we still have to approach in order to translate genomic and epigenomic data into clinical practice.
Vasculitis; Antineutrophil cytoplasmic antibody (ANCA); ANCA-associated vasculitis (AAV); Multifactorial disease; Genome-wide association studies (GWAS); Immunochip; Microscopic polyangiitis (MPA) Granulomatosis with polyangiitis (GPA); Eosinophilic granulomatosis with polyangiitis (EGPA)
Settore MED/14 - Nefrologia
2019
Book Part (author)
File in questo prodotto:
File Dimensione Formato  
AAV_book.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 8.78 MB
Formato Adobe PDF
8.78 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/690724
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact